Tesla, Rivian, and Uber Are Down Between 16% and 26%. Here's the Best Buy for the Robotaxi Takeover.

The article favors Uber as a robotaxi investment because it can partner with multiple autonomous-vehicle providers rather than relying on one technology stack; Tesla and Uber shares are each down about 16% in 2026, while Rivian is down roughly 26%. Uber has agreed to invest up to $1.25 billion in Rivian through 2031, tied to autonomy milestones, and may buy up to 50,000 autonomous Rivian robotaxis by 2030. The deployment plan starts with 10,000 R2-based robotaxis in San Francisco and Miami in 2028, with expansion to 25 cities by 2031; execution, profitability and cash-burn risks remain for Rivian.

Analysis

The key uncertainty is not whether robotaxis reduce driver labor; it is who captures that saving. Uber’s demand aggregation is valuable when autonomous supply is fragmented, but it does not guarantee margin expansion: fleet owners may keep the cost savings, providers may own the customer relationship, and competition among platforms could push fares or take rates down. Uber’s multi-partner strategy lowers dependence on any one autonomy stack, while increasing the risk that it is a replaceable booking channel rather than the system of record.

Rivian’s proposed role offers potential demand and milestone-linked funding, but leaves execution concentrated in vehicle economics, autonomy milestones, and the cash needs of its existing business. The 2028 deployment horizon makes this a weak near-term earnings catalyst; verify funding terms, milestone conditions, and R2 production economics before treating the commitment as de-risking. Tesla’s vertically integrated approach has the opposite payoff: more execution concentration, but potentially more value capture if its network scales. National expansion claims should be discounted until operating coverage and utilization are demonstrated.

Near term, expect headlines and deployment updates to drive sentiment more than material earnings. Over 1–3 months, track Uber’s disclosed autonomous-trip availability and unit economics, and Rivian’s milestone and funding updates. Over 6–18 months, the decisive evidence is repeat usage, utilization, and whether platforms or fleet operators capture savings. Contrarian point: Uber may be the better diversified exposure, but “robotaxis help Uber” is not equivalent to “robotaxis raise Uber margins.”

Key Decisions for Investors

• Consider a modest long UBER / short RIVN relative-value position only if valuation and borrow costs support it. The thesis is Uber’s diversified access to autonomous supply versus Rivian’s longer-dated, execution-dependent exposure—not a claim that Uber’s robotaxi margins are proven. Reassess on Rivian funding/milestone disclosures or evidence that Uber’s partners are taking bookings direct.
• Do not short TSLA solely on this comparison. Treat autonomous expansion as a catalyst to monitor, not an established earnings stream; require evidence of sustained driverless service, broader operating coverage, and utilization before underwriting the upside—or a timeline setback before adding downside exposure.
• Track Uber’s autonomous-trip share, take rate, fares, and partner/customer ownership. If robotaxi growth comes with lower take rates or weak repeat demand, the platform-beneficiary thesis is failing even if deployments expand.
• Track Rivian’s cash use, R2 production economics, and whether the stated investment is actually funded as milestones are met. Missed milestones, delayed deployments, or worsening liquidity would strengthen the short leg; demonstrated cost-effective production and on-schedule autonomy progress would falsify it.